Clearmind Medicine (CMND) Operating Leases (2022 - 2026)

Clearmind Medicine's Operating Leases history runs 5 years deep, the most recent figure standing at $44347.0 for Q2 2026.

• In Q2 2026, Operating Leases rose 23.25% year-over-year to $44347.0; the TTM figure through Apr 2026 stood at $44347.0 (up 23.25% YoY), while the FY2024 annual figure was $16416.0, changed N/A from the prior year.
• Operating Leases for Q2 2026 stood at $44347.0, up from $28439.0 in the prior quarter.
• The five-year high for Operating Leases was $44347.0 in Q2 2026, with the low at $4941.0 in Q2 2023.
• The 5-year median for Operating Leases is $27008.5 (2024), against an average of $24204.7.
• The sharpest annual moves came in 2024 and 2025: Operating Leases soared 52.3% in 2024, then plunged 77.37% in 2025.
• Clearmind Medicine's Operating Leases stood at $28903.7 in 2022, then sank by 82.91% to $4941.0 in 2023, then soared by 232.24% to $16416.0 in 2024, then soared by 73.24% to $28439.0 in 2025, then jumped by 55.94% to $44347.0 in 2026.
• Business Quant data shows CMND's Operating Leases at $44347.0 in Q2 2026, $28439.0 in Q3 2025, and $35982.0 in Q2 2025.